Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting

被引:398
作者
Smeeth, L
Cook, C
Thomas, S
Hall, AJ
Hubbard, R
Vallance, P
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England
[2] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[3] Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England
[4] UCL, British Heart Fdn Labs, Ctr Clin Pharmacol, London WC1E 6BT, England
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0140-6736(06)68474-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Acute infection increases the risk of arterial cardiovascular events, but effects on venous thromboembolic disease are less well established. Our aim was to investigate whether acute infections transiently increase the risk of venous thromboembolism. Methods We used the self-controlled case-series method to study the risk of first deep vein thrombosis (DVT) (n=7278) and first pulmonary embolism (PE) (n=3755) after acute respiratory and urinary tract infections. Data were obtained from records from general practices who had registered patients with the UK's Health Improvement Network database between 1987 and 2004. Findings The risks of DVT and PE were significantly raised, and were highest in the first two weeks, after urinary tract infection. The incidence ratio for DVT was 2.10 (95% CI 1.56-2.82), and that for PE 2.11 (1.38-3.23). The risk gradually fell over the subsequent months, returning to the baseline value after 1 year. The risk of DVT was also higher after respiratory tract infection, but possible diagnostic misclassification precluded a reliable estimate of the risk of PE after respiratory infection. Interpretation Acute infections are associated with a transient increased risk of venous thromboembolic events in a community setting. Our results confirm that infection should be added to the list of precipitants for venous thromboembolism, and suggest a causal relation.
引用
收藏
页码:1075 / 1079
页数:5
相关论文
共 22 条
  • [1] Risk factors for venous thromboembolism in hospitalized patients with acute medical illness - Analysis of the MEDENOX study
    Alikhan, R
    Cohen, AT
    Combe, S
    Samama, MM
    Desjardins, L
    Eldor, A
    Janbon, C
    Leizorovicz, A
    Olsson, CG
    Turpie, AGG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) : 963 - 968
  • [2] Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study
    Alikhan, R
    Cohen, AT
    Combe, S
    Samama, MM
    Desjardins, L
    Eldor, A
    Janbon, C
    Leizorovicz, A
    Olsson, CG
    Turpie, AGG
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (04) : 341 - 346
  • [3] Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430
  • [4] Bhagat K, 1996, CARDIOVASC RES, V32, P822
  • [5] Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo
    Bhagat, K
    Vallance, P
    [J]. CIRCULATION, 1997, 96 (09) : 3042 - 3047
  • [6] Bourke Alison, 2004, Inform Prim Care, V12, P171
  • [7] Control without separate controls: evaluation of vaccine safety using case-only methods
    Farrington, CP
    [J]. VACCINE, 2004, 22 (15-16) : 2064 - 2070
  • [8] RELATIVE INCIDENCE ESTIMATION FROM CASE SERIES FOR VACCINE SAFETY EVALUATION
    FARRINGTON, CP
    [J]. BIOMETRICS, 1995, 51 (01) : 228 - 235
  • [9] A NEW METHOD FOR ACTIVE SURVEILLANCE OF ADVERSE EVENTS FROM DIPHTHERIA-TETANUS-PERTUSSIS AND MEASLES MUMPS RUBELLA VACCINES
    FARRINGTON, P
    PUGH, S
    COLVILLE, A
    FLOWER, A
    NASH, J
    MORGANCAPNER, P
    RUSH, M
    MILLER, E
    [J]. LANCET, 1995, 345 (8949): : 567 - 569
  • [10] Incidence of diagnosed deep vein thrombosis in the general population: Systematic review
    Fowkes, FJI
    Price, JF
    Fowkes, FGR
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2003, 25 (01) : 1 - 5